280 related articles for article (PubMed ID: 2843021)
21. Side of ovulation and cycle characteristics in normally fertile women.
Ecochard R; Gougeon A
Hum Reprod; 2000 Apr; 15(4):752-5. PubMed ID: 10739814
[TBL] [Abstract][Full Text] [Related]
22. Direct assay of urinary steroid glucuronides for monitoring the approach of ovulation.
Merlo AB; Farinati Z; Quiroga S; Nagle CA; Carril LM; Lahoz M; Mendizabal AF
Int J Fertil; 1984; 29(3):189-93. PubMed ID: 6152260
[TBL] [Abstract][Full Text] [Related]
23. Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women.
Direito A; Bailly S; Mariani A; Ecochard R
Fertil Steril; 2013 Jan; 99(1):279-285.e3. PubMed ID: 22999798
[TBL] [Abstract][Full Text] [Related]
24. Measurement of estrone-3-glucuronide and pregnanediol-3 alpha-glucuronide in early morning urine samples to monitor ovarian function.
Magini A; Pinzani P; Bolelli GF; Bassi F; Salerno R; Messeri G; Pazzagli M
J Biolumin Chemilumin; 1989 Jul; 4(1):567-74. PubMed ID: 2801241
[TBL] [Abstract][Full Text] [Related]
25. Monitoring induction of ovulation by rapid radioimmunoassays of oestrogen and pregnanediol glucuronides.
MacLean AR; Outch KH; Russell JM; Brown JB; Dennis PM
Ann Clin Biochem; 1981 Nov; 18(Pt 6):343-9. PubMed ID: 7316453
[TBL] [Abstract][Full Text] [Related]
26. Characterization of reproductive hormonal dynamics in the perimenopause.
Santoro N; Brown JR; Adel T; Skurnick JH
J Clin Endocrinol Metab; 1996 Apr; 81(4):1495-501. PubMed ID: 8636357
[TBL] [Abstract][Full Text] [Related]
27. The development of over-the-counter (OTC) assays for pregnanediol-3-glucuronide and estrone-B,D-glucuronide.
Bahar I
Prog Clin Biol Res; 1988; 285():139-51. PubMed ID: 3231643
[TBL] [Abstract][Full Text] [Related]
28. The effect of ovarian follicle size on pituitary and ovarian responses to copulation in domesticated South American camelids.
Bravo PW; Stabenfeldt GH; Lasley BL; Fowler ME
Biol Reprod; 1991 Oct; 45(4):553-9. PubMed ID: 1751629
[TBL] [Abstract][Full Text] [Related]
29. Urinary ovarian and gonadotropin hormone levels in premenopausal women with low bone mass.
Sowers M; Randolph JF; Crutchfield M; Jannausch ML; Shapiro B; Zhang B; La Pietra M
J Bone Miner Res; 1998 Jul; 13(7):1191-202. PubMed ID: 9661084
[TBL] [Abstract][Full Text] [Related]
30. Plasma endothelin and LH-RH, LH, FSH, prolactin, progesterone, 17alpha-hydroxyprogesterone, estrone, 17beta-estradiol, delta4-androstenedione, testosterone, active renin, angiotensin-II and ANP levels in blood and LH, estrone and 17beta-estradiol and pregnanediol levels in urine of normal cycling women.
Usuki S; Kondoh K; Kubo T
J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S421-7. PubMed ID: 11078439
[TBL] [Abstract][Full Text] [Related]
31. Enhanced follicle regulatory protein levels accompany reinitiation of ovulatory function after parturition.
Albertson BD; Rodgers KE; Tomai TP; Nolan-Watson K; Zinaman MJ; DiZerega GS
Am J Obstet Gynecol; 1992 Jul; 167(1):158-62. PubMed ID: 1442919
[TBL] [Abstract][Full Text] [Related]
32. Feasibility of using paper impregnated with urine instead of liquid urine for assessing ovarian activity.
Wasalathanthri S; Tennekoon KH; Sufi S
Ceylon Med J; 2003 Mar; 48(1):4-6. PubMed ID: 12795010
[TBL] [Abstract][Full Text] [Related]
33. The prediction and/or detection of ovulation by means of urinary steroid assays.
Cekan SZ; Beksac MS; Wang E; Shi S; Masironi B; Landgren BM; Diczfalusy E
Contraception; 1986 Apr; 33(4):327-45. PubMed ID: 3731775
[TBL] [Abstract][Full Text] [Related]
34. Personal hormone monitoring for contraception.
Bonnar J; Flynn A; Freundl G; Kirkman R; Royston R; Snowden R
Br J Fam Plann; 1999 Jan; 24(4):128-34. PubMed ID: 10023097
[TBL] [Abstract][Full Text] [Related]
35. Measurement of glucuronometabolites of 17 beta-estradiol and progesterone in diluted overnight urine. An approach to the study of luteal insufficiency.
Pazzagli M; Magini A; Forti G; Bolelli G; Scarselli G; Noci I; Pellegrini S; Rodbard D; Serio M
J Steroid Biochem; 1987; 27(1-3):399-404. PubMed ID: 3695488
[TBL] [Abstract][Full Text] [Related]
36. Direct radioimmunoassay of urinary estrogen and pregnanediol glucuronides during the menstrual cycle.
Stanczyk FZ; Miyakawa I; Goebelsmann U
Am J Obstet Gynecol; 1980 Jun; 137(4):443-50. PubMed ID: 7386528
[TBL] [Abstract][Full Text] [Related]
37. Effect of low daily doses of mifepristone on ovarian function and endometrial development.
Danielsson KG; Swahn ML; Westlund P; Johannisson E; Seppälä M; Bygdeman M
Hum Reprod; 1997 Jan; 12(1):124-31. PubMed ID: 9043916
[TBL] [Abstract][Full Text] [Related]
38. Urinary beta-FSH subunit concentrations in perimenopausal and postmenopausal women: a biomarker for ovarian reserve.
Liu JH; Kao L; Rebar RW; Muse K
Menopause; 2003; 10(6):526-33. PubMed ID: 14627861
[TBL] [Abstract][Full Text] [Related]
39. Reproductive physiology and development of artificial insemination technology in killer whales (Orcinus orca).
Robeck TR; Steinman KJ; Gearhart S; Reidarson TR; McBain JF; Monfort SL
Biol Reprod; 2004 Aug; 71(2):650-60. PubMed ID: 15115725
[TBL] [Abstract][Full Text] [Related]
40. Characterizing daily urinary hormone profiles for women at midlife using functional data analysis.
Meyer PM; Zeger SL; Harlow SD; Sowers M; Crawford S; Luborsky JL; Janssen I; McConnell DS; Randolph JF; Weiss G
Am J Epidemiol; 2007 Apr; 165(8):936-45. PubMed ID: 17267418
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
